Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2006 1
2007 6
2008 5
2009 1
2010 3
2011 1
2012 3
2013 6
2014 8
2015 7
2016 5
2017 6
2018 8
2019 7
2020 8
2021 6
2022 7
2023 8
2024 3
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
The chromosomal basis of cancer.
Duesberg P, Li R, Fabarius A, Hehlmann R. Duesberg P, et al. Among authors: fabarius a. Cell Oncol. 2005;27(5-6):293-318. doi: 10.1155/2005/951598. Cell Oncol. 2005. PMID: 16373963 Free PMC article. Review.
Aneuploidy and cancer: from correlation to causation.
Duesberg P, Li R, Fabarius A, Hehlmann R. Duesberg P, et al. Among authors: fabarius a. Contrib Microbiol. 2006;13:16-44. doi: 10.1159/000092963. Contrib Microbiol. 2006. PMID: 16627957 Review.
Impact of emerging ACA on survival in chronic myeloid leukemia (CML).
Hehlmann R, Lauseker M, Voskanyan A, Fabarius A, Haferlach C, Hochhaus A, Saußele S. Hehlmann R, et al. Among authors: fabarius a. Leukemia. 2022 Oct;36(10):2544-2547. doi: 10.1038/s41375-022-01681-3. Epub 2022 Aug 23. Leukemia. 2022. PMID: 35999258 Free PMC article. No abstract available.
Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies.
Xu Q, Streuer A, Jann JC, Altrock E, Schmitt N, Flach J, Sens-Albert C, Rapp F, Wolf J, Nowak V, Weimer N, Obländer J, Palme I, Kuzina M, Jawhar A, Darwich A, Weis CA, Marx A, Wuchter P, Costina V, Jäger E, Sperk E, Neumaier M, Fabarius A, Metzgeroth G, Nolte F, Steiner L, Levkin PA, Jawhar M, Hofmann WK, Riabov V, Nowak D. Xu Q, et al. Among authors: fabarius a. Nat Commun. 2023 Mar 17;14(1):1497. doi: 10.1038/s41467-023-37175-8. Nat Commun. 2023. PMID: 36932114 Free PMC article.
Leukocytosis, Monocytosis, and Eosinophilia in Systemic Mastocytosis: Analysis of Phenotype, Genetics and Prognosis in 596 Patients From the GREM Registry.
Lübke J, Naumann N, Dangelo V, Fabarius A, Metzgeroth G, Horny HP, Sotlar K, Hofmann WK, Rudelius M, Schwaab J, Reiter A. Lübke J, et al. Among authors: fabarius a. J Allergy Clin Immunol Pract. 2026 Jan;14(1):103-113.e9. doi: 10.1016/j.jaip.2025.09.018. Epub 2025 Sep 24. J Allergy Clin Immunol Pract. 2026. PMID: 41005704 Free article.
Cancer drug resistance: the central role of the karyotype.
Duesberg P, Li R, Sachs R, Fabarius A, Upender MB, Hehlmann R. Duesberg P, et al. Among authors: fabarius a. Drug Resist Updat. 2007 Feb-Apr;10(1-2):51-8. doi: 10.1016/j.drup.2007.02.003. Epub 2007 Mar 26. Drug Resist Updat. 2007. PMID: 17387035 Review.
MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis.
Jawhar M, Schwaab J, Álvarez-Twose I, Shoumariyeh K, Naumann N, Lübke J, Perkins C, Muñoz-González JI, Meggendorfer M, Kennedy V, Metzgeroth G, Fabarius A, Pfeifer D, Sotlar K, Horny HP, von Bubnoff N, Haferlach T, Cross NCP, Hofmann WK, Sperr WR, García-Montero AC, Valent P, Gotlib J, Orfao A, Reiter A. Jawhar M, et al. Among authors: fabarius a. J Clin Oncol. 2019 Nov 1;37(31):2846-2856. doi: 10.1200/JCO.19.00640. Epub 2019 Sep 11. J Clin Oncol. 2019. PMID: 31509472 Free PMC article.
98 results